Literature DB >> 34939175

Morphometric analysis program and quantitative positron emission tomography in presurgical localization in MRI-negative epilepsies: a simultaneous PET/MRI study.

Kun Guo1, Jingjuan Wang1, Zhenming Wang1, Yihe Wang2, Bixiao Cui1, Guoguang Zhao2, Jie Lu3,4.   

Abstract

PURPOSE: To evaluate morphometric analysis program (MAP) and quantitative positron emission tomography (QPET) in epileptogenic zone (EZ) identification using a simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI) system in MRI-negative epilepsies.
METHODS: Seventy-one localization-related MRI-negative epilepsies who underwent preoperative simultaneous PET/MRI examination and surgical resection were enrolled retrospectively. MAP was performed on a T1-weighted volumetric sequence, and QPET was analyzed using statistical parametric mapping (SPM) with comparison to age- and gender-matched normal controls. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MAP, QPET, MAP + QPET, and MAP/QPET in EZ localization were assessed. The correlations between surgical outcome and modalities concordant with cortical resection were analyzed.
RESULTS: Forty-five (63.4%) patients had Engel I seizure outcomes. The sensitivity, specificity, PPV, and NPV of MAP were 64.4%, 69.2%, 78.3%, and 52.9%, respectively. The sensitivity, specificity, PPV, NPV of QPET were 73.3%, 65.4%, 78.6%, and 58.6%, respectively. MAP + QPET, defined as two tests concordant with cortical resection, had reduced sensitivity (53.3%) but increased specificity (88.5%) relative to individual tests. MAP/QPET, defined as one or both tests concordant with cortical resection, had increased sensitivity (86.7%) but reduced specificity (46.2%) relative to individual tests. The regions determined by MAP, QPET, MAP + QPET, or MAP/QPET concordant with cortical resection were significantly associated with the seizure-free outcome.
CONCLUSION: QPET has a superior sensitivity than MAP, while the combined MAP + QPET obtained from a simultaneous PET/MRI scanner may improve the specificity of the diagnostic tests in EZ localization coupled with the preferable surgical outcome in MRI-negative epilepsies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Epilepsy; Localization; MAP; PET/MRI; Quantitative PET

Mesh:

Year:  2021        PMID: 34939175     DOI: 10.1007/s00259-021-05657-w

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  22 in total

1.  Glucose Metabolic Profile by Visual Assessment Combined with Statistical Parametric Mapping Analysis in Pediatric Patients with Epilepsy.

Authors:  Yuankai Zhu; Jianhua Feng; Shuang Wu; Haifeng Hou; Jianfeng Ji; Kai Zhang; Qing Chen; Lin Chen; Haiying Cheng; Liuyan Gao; Zexin Chen; Hong Zhang; Mei Tian
Journal:  J Nucl Med       Date:  2017-01-19       Impact factor: 10.057

2.  Efficacy of delayed 18F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study.

Authors:  Fang Liu; Weiwei Ruan; Xuejun Deng; Yangmeihui Song; Wenyu Song; Fan Hu; Jinxia Guo; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-25       Impact factor: 9.236

3.  Epilepsy: Long-term outcomes in MRI-negative patients with epilepsy.

Authors:  Kristina Malmgren; David Krýsl
Journal:  Nat Rev Neurol       Date:  2017-03-02       Impact factor: 42.937

4.  Voxel-based morphometric magnetic resonance imaging (MRI) postprocessing in MRI-negative epilepsies.

Authors:  Z Irene Wang; Stephen E Jones; Zeenat Jaisani; Imad M Najm; Richard A Prayson; Richard C Burgess; Balu Krishnan; Aleksandar Ristic; Chong H Wong; William Bingaman; Jorge A Gonzalez-Martinez; Andreas V Alexopoulos
Journal:  Ann Neurol       Date:  2015-04-23       Impact factor: 10.422

5.  The Role of SPECT and PET in Epilepsy.

Authors:  Maria R Ponisio; John M Zempel; Brian K Day; Lawrence N Eisenman; Michelle M Miller-Thomas; Matthew D Smyth; R Edward Hogan
Journal:  AJR Am J Roentgenol       Date:  2021-01-21       Impact factor: 3.959

6.  Morphometric MRI analysis improves detection of focal cortical dysplasia type II.

Authors:  Jan Wagner; Bernd Weber; Horst Urbach; Christian E Elger; Hans-Jürgen Huppertz
Journal:  Brain       Date:  2011-09-05       Impact factor: 13.501

7.  Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.

Authors:  Yu Kyeong Kim; Dong Soo Lee; Sang Kun Lee; Seok-Ki Kim; Chun Kee Chung; Ki Hyun Chang; Ki Young Choi; June-Key Chung; Myung Chul Lee
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

8.  Seizure-onset zone localization by statistical parametric mapping in visually normal (18) F-FDG PET studies.

Authors:  Maria Mayoral; Berta Marti-Fuster; Mar Carreño; Josep L Carrasco; Núria Bargalló; Antonio Donaire; Jordi Rumià; Andrés Perissinotti; Francisco Lomeña; Luis Pintor; Teresa Boget; Xavier Setoain
Journal:  Epilepsia       Date:  2016-06-11       Impact factor: 5.864

Review 9.  Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy.

Authors:  Jonah Peter; Sina Houshmand; Thomas J Werner; Domenico Rubello; Abass Alavi
Journal:  Nucl Med Commun       Date:  2016-03       Impact factor: 1.690

10.  Voxel-based morphometric MRI post-processing and PET/MRI co-registration reveal subtle abnormalities in cingulate epilepsy.

Authors:  Ke Sun; Zhiwei Ren; Dongju Yang; Xueyuan Wang; Tao Yu; Duanyu Ni; Liang Qiao; Cuiping Xu; Runshi Gao; Yicong Lin; Xiating Zhang; Kun Shang; Xin Chen; Yajie Wang; Guojun Zhang
Journal:  Epilepsy Res       Date:  2021-02-08       Impact factor: 3.045

View more
  8 in total

1.  Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma.

Authors:  Liang Zhao; Yizhen Pang; Yuhuan Wang; Jianhao Chen; Yanzhen Zhuang; Jingjing Zhang; Long Zhao; Long Sun; Hua Wu; Xiaoyuan Chen; Qin Lin; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-19       Impact factor: 9.236

2.  18F- or 177Lu-labeled bivalent ligand of fibroblast activation protein with high tumor uptake and retention.

Authors:  Hongsheng Li; Shimin Ye; Jiawei Zhong; Qingsong Yan; Yuhua Zhong; Pengju Feng; Kongzhen Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-15       Impact factor: 10.057

3.  [18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04.

Authors:  Kongzhen Hu; Lijuan Wang; Hubing Wu; Shun Huang; Ying Tian; Qiaoyu Wang; Caixia Xiao; Yanjiang Han; Ganghua Tang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-11       Impact factor: 10.057

4.  Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement.

Authors:  Umut Elboga; Ertan Sahin; Tulay Kus; Yusuf Burak Cayirli; Gokmen Aktas; Merve Okuyan; Havva Yesil Cinkir; Fatih Teker; Ozlem Nuray Sever; Alper Aytekin; Latif Yılmaz; Aydın Aytekin; Ufuk Cimen; Vuslat Mumcu; Benan Kilbas; Kurtulus Eryilmaz; Davut Cakici; Yusuf Zeki Celen
Journal:  Mol Imaging Biol       Date:  2022-04-11       Impact factor: 3.484

5.  State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956-2022).

Authors:  Xiaoli Lan; Li Huo; Shuren Li; Jing Wang; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07       Impact factor: 10.057

6.  Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.

Authors:  Chunxia Qin; Yangmeihui Song; Xi Liu; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-09       Impact factor: 10.057

7.  Image enhancement of whole-body oncology [18F]-FDG PET scans using deep neural networks to reduce noise.

Authors:  Abolfazl Mehranian; Scott D Wollenweber; Matthew D Walker; Kevin M Bradley; Patrick A Fielding; Kuan-Hao Su; Robert Johnsen; Fotis Kotasidis; Floris P Jansen; Daniel R McGowan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-28       Impact factor: 9.236

8.  FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies.

Authors:  K Dendl; R Finck; F L Giesel; C Kratochwil; T Lindner; W Mier; J Cardinale; C Kesch; M Röhrich; H Rathke; H Gampp; J Ristau; S Adeberg; D Jäger; J Debus; U Haberkorn; S A Koerber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-03       Impact factor: 10.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.